Patients with chronic kidney disease, heart failure, and diabetes are at increased risk for hyperkalemia and warrant consistent care across nephrology and cardiology, according to the authors of a new ...

Please provide your email address to receive an email when new articles are posted on . After a hyperkalemia event, mineralocorticoid receptor antagonists were discontinued in up to 46% of patients.